David Kang

Bio:

David Kang is Director of Drug Delivery and Innovation at Halozyme Therapeutics. He is a subject matter expert in recombinant human hyaluronidase facilitated rapid, high-volume subcutaneous drug delivery for nearly two decades. Prior to Halozyme, David spent over 10 years between Pfizer and Schering-Plough researching oncology therapeutics and viral based gene delivery.  He started his research career at the University of California at San Diego working on gene therapy approaches on infectious disease, where we also did his undergraduate studies in microbiology and graduate work in virology.